Sterile Packaging Industry Articles

Arranta Bio Announces First End-to-End Manufacturing for mRNA Vaccines in its Commercial-ready GMP Facility

Arranta Bio (“Arranta”), a leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, today announced plans to establish contract manufacturing capacity for messenger RNA (mRNA) vaccines.

Boston Labs and Germfree Launch Mobile Cell and Gene Therapy (CGT) Manufacturing Platform

Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. today announced their partnership to launch a new network of mobile CGT manufacturing facilities.

Precision Coating Announces Merger with N2 Biomedical to Expand Medical Device Coating Platform

Precision Coating, a leading medical coatings service provider to interventional, orthopedic, and advanced surgical markets, is pleased to announce a merger with N2 Biomedical, a Bedford, MA-based company.

ISPE Boston Product Show Coming to Gillette Stadium

The Annual ISPE Boston Product Show is the premier one-day biopharmaceutical show in the Northeast and the flagship event of the ISPE Boston Area Chapter.

Watson-Marlow announces details of the new U.S. manufacturing facility bringing them closer to customers in the region

Watson-Marlow announces details of the new U.S. manufacturing facility bringing them closer to customers in the region

Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.

Phillips-Medisize Increases Global Manufacturing Capacity

Phillips-Medisize Increases Global Manufacturing Capacity

Phillips-Medisize, announces the expansion of its global manufacturing footprint, along with extended product design, development and manufacturing capabilities to streamline the delivery of game-changing products and solutions.

Pepscan Doubles GMP Production Capacity to Facilitate Clients’ Growth

Pepscan Doubles GMP Production Capacity to Facilitate Clients’ Growth

Pepscan announced that its GMP production capacity has doubled. Pepscan is an all-in-one partner in peptides, building on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides.

read more
VetStem Biopharma Secures FDA Approval of First Human IND

VetStem Biopharma Secures FDA Approval of First Human IND

VetStem Biopharma, a veterinary and human regenerative medicine CRO, used its extensive experience, FDA master files, and database of veterinary stem cell therapy to secure FDA approval of a human IND for stem cell therapy in patients with osteoarthritis. VetStem made the application to FDA on behalf of its subsidiary, Personalized Stem Cells, Inc.

read more
GSK Opens New Pharmaceutical Manufacturing Facilities worth $130m

GSK Opens New Pharmaceutical Manufacturing Facilities worth $130m

Multinational pharmaceutical company GlaxoSmithKlyne (GSK) launched two new pharmaceutical manufacturing facilities and an expanded production building at its Jurong site. According to GSK, the new and expanded sites will allow the faster production of drugs and Active Pharmaceutical Ingredients (APIs) for clinical trials.

read more
Romaco China gains a new processing laboratory

Romaco China gains a new processing laboratory

More than 500 invited guests and customers of Romaco China and Truking recently attended the official opening of the new “Romaco China Solids Process Centre”. This high-tech laboratory on the Truking campus in Changsha is equipped with Innojet and Kilian machines.

read more
Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

Precigen commenced the build-out of the nearly 5,000 square foot manufacturing facility in 2018 to support gene therapy manufacturing. The good manufacturing practices (GMP) facility was designed with agility and control in mind, focusing on rapid manufacturing and the ability to scale production appropriately to meet early stage clinical trial needs.

read more